BACKGROUND
In the United States, 15,600 nursing homes (NHs) provide care to >3 million people each year.
1,2 A frequently cited publication from 2000 estimates that between 1.6 and 3.8 million healthcareassociated infections (HAIs) occur in U.S. NHs in a single year. 3 A more recent publication estimated that 1.13-2.68 million infections occurred among NH residents in 2013; although the proportion of HAIs was not known. 4 In an effort to increase infection surveillance in NHs, in September 2012 the Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network (NHSN) launched an infection reporting infrastructure designed specifically for use among long-term care facilities (LTCFs), including NHs, assisted living facilities, and other chronic care facilities. 5 The NHSN LTCF Component represents the first surveillance system for tracking infection incidence available to all LTCFs across the United States. Facilities enrolled in the system are able to monitor Clostridium difficile infections (CDIs), urinary tract infections (UTIs), and infections due to multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus (MRSA), and infection prevention process measures.
Availability of this system creates an opportunity to improve HAI awareness among LTCF leadership and staff, estimate HAI burden, and evaluate trends in rates over time. Unlike for hospitals, reporting to the NHSN is currently voluntary for most LTCFs. The Centers for Medicare & Medicaid Services (CMS) has not included HAI reporting to the NHSN as part of quality reporting or payment incentive programs for NHs. Therefore, focused efforts to promote facility enrollment and reporting to the NHSN will be critical to obtain data to understand the HAI epidemiology in this setting. In this article, we describe characteristics of LTCFs enrolled during the first 3 years of the NHSN LTCF Component, present reporting patterns of the enrolled facilities, and summarize crude infection rates using data from January 2013-December 2015.
METHODS
Facilities enrolled in the NHSN are required to submit an annual survey of facility characteristics, a reporting plan outlining the event(s) they plan to report for each month of participation, and event data and summary denominator data through passive surveillance each month for each event indicated on the plan. 5 
Inclusion and exclusion criteria
Facilities enrolled between January 1, 2013, and December 31, 2015, were considered eligible to report to the system. Facilities submitting at least 1 monthly reporting plan were included in the analysis of reporting patterns. Analysis of CDI, MRSA, and UTI rates included only completed months, defined as months where facilities submitted both numerator (events) and denominator (resident days) data for these events.
Definitions
The Laboratory-identified (LabID) Event module enables facilities to report CDIs and infections caused by antibiotic-resistant organisms, identified using a positive laboratory specimen. LabID events are classified as LTCF-onset, community-onset, or acute care transfer-LTCF-onset using admission date and specimen collection date. LTCF-onset events are defined as specimens collected >3 calendar days after the current facility admission date, whereas community-onset events are defined as specimens collected on the first 3 days of the current facility admission (ie, days 1, 2, or 3 of admission). Finally, acute-care transfer-LTCF-onset events are defined as LTCF-onset events where the specimen was collected ≤4 weeks after the resident's last transfer from an acute care facility. For CDI events, the surveillance system determines whether the event was an incident infection, defined as an event that is either the first CDI event reported for an individual, or a CDI event reported >8 weeks after an individual's previous CDI event. 6 The Healthcare Associated Infection Surveillance module enables facilities to report UTIs defined using the revised McGeer definitions 7 and classified as either symptomatic UTI (SUTI) if the resident has signs and symptoms as described in the module protocol in addition to a positive urine culture or catheter-associated SUTI (CA-SUTI) if the SUTI occurred in the presence of an indwelling urinary catheter. The catheter utilization ratio, a measure of residents' exposure to indwelling urinary catheters, is defined as total urinary catheter days divided by the total resident days. 8 
Data analyses
Geographic patterns were analyzed among all eligible facilities. Facility characteristics from the annual facility survey were summarized using frequencies for categorical variables and medians and interquartile ranges for continuous variables. Reporting patterns, determined from monthly reporting plans and summary data for January 2013-December 2015, were analyzed. The frequency of selected events and percent completion were summarized for all monthly reporting plans. Data were defined as complete for the month if the facility reported both numerator and denominator data, which was specific to the event selected. Reporting for UTIs, MDROs, or CDIs was defined as complete if the facility reported event count and resident days data. Reporting for hand hygiene was defined as complete if the facility reported number of observed contacts where a health care provider performed hand hygiene and number of observed contacts where hand hygiene was indicated. Reporting for gown and glove use was defined as complete if the facility reported number of observed contacts where gown and gloves were used and number of observed contacts where gown and gloves were indicated.
Reporting patterns for each year were examined for all events combined and for CDI, MRSA, and UTI specifically. When looking at all events combined, if facilities selected >1 event on their reporting plan, reporting only needed to be completed for at least 1 event for that month to be considered complete. Facilities were categorized as a consistent reporter if they completed at least 6 months of reporting within a calendar year. The number of consecutive reporting months within a calendar year was calculated as the sum of the number of months completed in succession after the first month of completed data.
Rate data were analyzed for CDI, MRSA, and UTI. We calculated the overall (all facilities) pooled 3-year crude rate for incident LTCFonset CDI, LTCF-onset MRSA, total UTI, SUTI, and CA-SUTI and the percentile distribution of facility-level rates for these events. Similarly, an overall catheter utilization ratio and facility-level distribution of catheter utilization ratio were calculated. We excluded extreme outliers from rate calculations, defined as facilities with <100 total resident days reported for the 3-year time period. All analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC).
RESULTS

Facility characteristics
A total of 279 LTCFs were enrolled in the NHSN LTCF Component on or before December 31, 2015, and eligible to report between January 2013 and December 2015. These facilities represented 40 states and Washington, DC (Fig 1) .
Most facilities were nonprofit (57%), 91% were Medicare and Medicaid dual certified, and 38% were independent. The median number of beds was 102, and median occupancy was approximately 92%. Only 21% of facilities had their own laboratory for testing of specimens (Table 1 ).
All but 2 enrolled facilities were NHs; these 2 facilities did not submit any reporting plans or data during the 3-year period. The results that follow are for the 277 NHs.
Reporting patterns
Based on the enrollment date for each facility, the maximum number of months of reporting for the 277 NHs was 6,104, and a total of 2,717 (45%) monthly reporting plans were submitted. Most (216) NHs submitted at least 1 monthly reporting plan during the 3-year period and selected to report 8 different event types and 2 infection prevention process measures ( Table 2 ). The reporting patterns and data for only the 3 most common event types selected for reporting are summarized further.
Between 2013 and 2015, 216 (78%) of 277 unique NHs submitted at least 1 monthly reporting plan. During the 3-year period, 147 unique NHs completed at least 1 month of CDI reporting, 84 unique NHs completed at least 1 month of MRSA reporting, and 114 unique NHs completed at least 1 month of UTI reporting. Reporting patterns for each year are presented in Table 3 . In 2013, 85% of 110 NHs completed reporting for at least 1 event type, and among those NHs, 75% were consistent reporters. In 2014, the percent of consistent reporters dropped to 47%, but increased to 76% in 2015. Similarly, the median number of consecutive months was 6.5 in 2013, dropped to 4 months in 2014, and increased to 6 months in 2015.
Regardless of event type (CDI, MRSA, or UTI), 3 overall reporting patterns emerged over the 3-year period. First, the number of NHs completing at least 1 month of reporting increased between 2013 and 2015. Second, the number of NHs defined as consistent reporters in 2015 increased from 2013. Third, for all events, the percent of facilities reporting consistently decreased between 2013 and 2014 before increasing again in 2015 (Table 3) .
Infection rates
Between 2013 and 2015, 147 NHs completed at least 1 month of CDI reporting. Incident LTCF-onset CDI rates were calculated for 146 NHs (1 outlier was excluded). A total of 667 incident LTCFonset CDI events and 6,827,414 resident days were reported. Zero CDI events were reported by 52 (36%) NHs. The pooled 3-year rate was 0.98 incident LTCF-onset CDI events per 10,000 resident days, and the median facility-level rate was 0.70 incident LTCF-onset CDI events per 10,000 resident days (Table 4) .
A total of 84 NHs completed ≥1 month of MRSA reporting. A total of 206 LTCF-onset MRSA events and 2,161,396 resident days were reported. Of note, 50% of NHs reported zero MRSA events. The pooled 3-year rate was 0.10 LTCF-onset MRSA events per 1,000 resident days (Table 4) .
A total of 114 NHs completed ≥1 month of UTI reporting. From 112 NHs eligible for the UTI rate analysis (2 outliers excluded), a total of 2,013 UTI events and a total of 3,429,240 resident days were reported, for a pooled 3-year rate of 0.59 UTI events per 1,000 resident days. Of these 112 NHs, 31 NHs (28%) reported zero UTI events. Zero denominator calculations required additional exclusions for SUTI and catheter-associated SUTI analyses. An additional 2 NHs (4 total) were excluded from the SUTI rate analysis because of reporting zero noncatheter resident days for the 3-year period, and an additional 3 NHs (5 total) were excluded from the catheter-associated SUTI rate analysis because of reporting zero urinary catheter days for the 3-year period (Table 4) .
DISCUSSION
The NHSN LTCF Component helps to fill existing gaps in our understanding of the HAI incidence in LTCFs and to identify facilitylevel benchmarks that can be used to improve resident safety. Our report also describes characteristics of early users of the NHSN LTCF Component and the reporting patterns of HAI surveillance data among these users.
The characteristics of facilities reporting to the NHSN LTCF Component during 2013-2015 are somewhat different from those of all NHs in the United States. Almost 70% of NHs in the United States are for profit, whereas 24% are not for profit 1 ; however, among NHSN early enrollees, not-for-profit facilities were overrepresented, making up 57% of the enrolled facilities, whereas only 34% were for profit. Furthermore, in 2014, approximately 56% of all NHs were part of a multifacility chain, 9 but only 26% of the NHSN population identified as chain-affiliated. Finally, a greater proportion of the NHSNenrolled facilities (27%) were attached to a hospital compared with the 5% proportion of hospital-based nursing facilities reported nationwide. 10 Although we expect these differences to change as enrollment increases, understanding if the early enrollees also differed in infection prevention staffing and infrastructure compared with all U.S. NHs will inform whether these factors may have allowed them to overcome barriers to enrollment and reporting. In addition, understanding the influence of other external factors will be important to promoting participation. As illustrated in Figure 1 , certain states have been more successful in enrolling facilities in the NHSN, particularly states with collaboratives and state mandates focused on NHSN reporting. For example, Nevada is the only state with a mandate for NHSN enrollment and reporting among skilled nursing facilities. 11, 12 Additionally, the Vermont Department of Health supported training and enrollment of LTCFs in the NHSN during these early reporting years through state collaboratives. 13 Therefore, understanding if the presence of state collaboratives and legislation influenced some of the differences we see in the number of facilities enrolled in the NHSN between states may inform promotion and enrollment efforts. When comparing NHSN data for NH CDI, UTI, and MRSA incidence rates to the literature on HAIs in long-term care and other surveillance data, we found the total NHSN LTCF-onset CDI pooled 3-year rate of 0.98 per 10,000 resident days was similar to the CDI HAI rate of 0.8 per 10,000 resident days reported by the Pennsylvania Patient Safety Authority for 483 Pennsylvania NHs in 2015.
14 A comparable pooled LTCF-onset rate of 1.98 events per 10,000 resident days was also calculated from Department of Veterans Affairs LTCFs. 15 A single county performing laboratory-based CDI surveillance in 2010 reported an LTCF-onset CDI incidence rate of 2.3 per 10,000 resident days from surveillance data from 33 LTCFs. 16 However, the higher rate in this study compared with the NHSN rate may have been because of the identification of CDI events diagnosed during a hospital admission and attributed back to an LTCF; whereas in the NHSN, CDI events diagnosed during a care transition (eg, at the time of a hospitalization) would not be reported by the LTCF.
The catheter-associated UTI rate of 0.81 cases per 1,000 catheter days based on data from 350 Pennsylvania NHs reporting to the Pennsylvania Patient Safety Authority is much lower than the pooled crude rate of 2.39 cases per 1,000 catheter days calculated from the NHSN but is comparable with the median facility-level rate of 0.84 per 1,000 catheter days from the NHSN. 14 The presence of data from outlier facilities with high rates may account for some of the difference between the pooled crude 3-year rate and the median facility-level rate within the NHSN. The catheter utilization ratio calculated from Pennsylvania NHs was almost identical to the ratio calculated from the NHSN (0.048 vs 0.050, respectively).
14 Although the NHSN SUTI rate is usually calculated using a noncatheter resident day denominator, when we used total resident days, we found the calculated NHSN SUTI rate of 0.46 per 1,000 resident days was higher than the rate of 0.16 per 1,000 resident days reported by 473 Pennsylvania NHs. 14 One study of Department of Veterans Affairs LTCFs reported that their healthcare-associated MRSA rate decreased from 0.25 to 0.16 cases per 1,000 resident days between July 2009 and December 2012. 17 Although a different population of NHs than those reporting to the NHSN, their MRSA infection rate is similar to the overall pooled rate of 0.10 per 1,000 resident days from the NHSN. We found few publications or reports providing comparative data of HAI incidence in LTCFs, reinforcing the importance of the NHSN as a resource to generate data on HAI epidemiology and burden in this health care setting.
In our analysis, we were also able to look at consistent reporting, defined as facilities that completed at least 6 months of reporting within a calendar year. We found variability in the consistency of reporting from year to year. Between 2013 and 2014 there was a 37% drop overall in the percent of NHs reporting consistently, primarily attributed to the loss in states with more consistent reporters (data not shown). Consistent reporters increased again in 2015, which was not because of recovery of previous consistent reporters, but because of the addition of new consistent reporters in other states. Evaluation of factors associated with consistent reporting to the NHSN, such as the role of state HAI programs or participation in regional HAI prevention collaboratives, is necessary to develop interventions that support and maintain NH participation in NHSN surveillance. As more NHs gain experience with surveillance and engage in consistent reporting, we anticipate the quantity and quality of the data available to estimate HAI rates in NHs will improve.
Beginning in 2016, the CMS announced a CDI reporting and reduction project within the 11th Scope of Work contract for Quality Innovation Network-Quality Improvement Organizations. This national initiative will promote NHSN enrollment and reporting by facilities across the country and demonstrate whether NHs have the capacity to use the NHSN on a larger scale. The CDC is working closely with the CMS and the Quality Innovation Network-Quality Improvement Organizations to support this effort to facilitate enrollment and reporting. Although the current NHSN data are not able to provide a nationally representative benchmark for NHs, as participation increases through efforts like the CDI reporting project, there will be a stable CDI reporting experience to provide data to inform both facility-level and national public health prevention efforts.
Several limitations must be taken into account when interpreting the findings reported. First, only 2% of all NHs in the United States contributed data for this analysis, and this small sample is not representative of all NHs in the United States (eg, 10 states did not have any facilities enrolled in the NHSN). Therefore, these findings should not be generalized to NHs nationwide. Second, the reporting population in the NHSN is not stable from one year to the next, which limits the comparison of rates from different years. To overcome this instability and maximize use of all available data, we pooled data for the 3-year period. Third, our analysis of the data revealed some extreme outliers with high infection rates, which may have been caused by errors in denominator reporting. To help limit the influence of possible data entry errors, we established a minimum denominator threshold of 100 resident days for inclusion in the rate calculations. However, other undetected data entry errors could have remained. Finally, the high proportion of facilities reporting zero events during the 3-year period raises concerns about the consistent identification and reporting of HAI events by NHs. The CDC is working with NHs reporting to the NHSN to understand if variation in diagnostic testing practices or surveillance could impact reporting of CDI and MRSA because the NHSN uses positive laboratory tests as a proxy for infection. This report provides the first summary of data reported to the NHSN LTCF Component including incidence rates for UTI and LabID MRSA and CDI events. The NHSN LTCF Component is the only surveillance system available to all NHs in the United States to report HAIs, and the data generated from this system fill an important gap. Current participation enabled us to summarize the top 3 events selected for reporting. The CDC is working to evaluate factors associated with success in enrollment and reporting among these early enrollees to inform ongoing efforts to promote participation and reporting in the NHSN. As participation increases, the data will be used to establish a national baseline for LTCF-onset infection rates and provide an opportunity for facilities to evaluate their own individual progress compared with this baseline. Access to benchmarking data for NHs could make NHSN reporting a more meaningful and useful effort for facilities by providing actionable data to improve resident safety. Furthermore, these data will be used to track the national progress toward HAI prevention goals for LTCFs and identify opportunities to target prevention efforts to reduce resident harms from infections in this setting.
